Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3847333 | Advances in Chronic Kidney Disease | 2007 | 8 Pages |
Abstract
Use of prescription and nonprescription medications is common during pregnancy and is required in many women with underlying kidney disease or hypertension and in all with solid-organ allografts. Systematic assessment of drug safety during pregnancy is lacking, as are rigorous and comprehensive studies of pharmacokinetics and pharmacodynamics to guide drug selection and dosing across pregnancy. Renal and hepatic clearances of many drugs change markedly during pregnancy and pitfalls may complicate routine therapeutic monitoring of some drugs during pregnancy. However, available data and clinical experience allow reasonable strategies for selection and dosing of immunosuppressive agents in pregnant transplant recipients and of antihypertensive agents in women with mild or more severe hypertension complicating their pregnancies.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Jason G. Umans,